Association between aspirin use and cardiovascular outcomes in ALLHAT participants with and without chronic kidney disease: A post hoc analysis

Association between aspirin use and cardiovascular outcomes in ALLHAT participants with and without chronic kidney disease: A post hoc analysis

Abstract It is unclear whether aspirin is beneficial for prevention of CVD in patients with CKD. We performed a secondary analysis of the ALLHAT trial to assess the effect of baseline aspirin use on nonfatal myocardial infarction (MI) or fatal coronary heart disease (CHD), all‐cause mortality, and s...

Full description

Bibliographic Details
Main Authors: Niraj Desai, Brigid Wilson, Michael Bond, Alexander Conant, Mahboob Rahman
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:The Journal of Clinical Hypertension
Subjects:
aspirin
cardiovascular disease
CKD
Online Access:https://doi.org/10.1111/jch.14091

Similar Items

Similar Items